[High effectiveness of taxol in advanced ovarian cancer].
D017322:Clinical Trials, Phase II as Topic; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage* / Q000009:adverse effects; D015996:Survival Rate
D017239:Paclitaxel
Hohe Wirksamkeit von Taxol bei fortgeschrittenem Ovarialkarzinom.